Please review the following disclaimer carefully. By selecting “I ACCEPT” below, you acknowledge that you have read the following disclaimer and agree to the restrictions contained therein, and confirm that you are entering the website and obtaining access to the documents and information it contains from the territory of the Republic of Poland or in accordance with the provisions of the local jurisdiction you are subject to which provide for such authorisation.
The only legally binding offer document with information concerning the public offer for the shares of Mercator Medical S.A. (the “Company”) in the territory of the Republic of Poland and concerning the Company’s request for admission and introduction of Company’s securities to trading on a regulated market operated by the Warsaw Stock Exchange S.A. is a prospectus together with any appendices thereto and update notices (the “Prospectus”), which was approved by the Polish Financial Supervision Authority on 18.10.2013. The Prospectus has been published and is available on the Company’s website (www.mercatormedical.eu) and on the website of the Investment Firm – Brokerage House of Bank Ochrony Środowiska S.A.: (www.bossa.pl).
Before making any investment decision, investors should read the whole Prospectus carefully, in particular information about the risks associated with investing in shares described in the Prospectus sections titled “Risk factors”, and the conditions of the public offer of the Company’s shares. All investment decisions relating to the acquisition of the Company’s securities should be taken after analysis of the entire Prospectus.
The information and materials provided on this website are not intended for publication or distribution outside the Republic of Poland.
The public offer of Mercator Medical S.A. shares is carried out exclusively in the territory of the Republic of Poland, and outside its borders this Prospectus may not be treated as an offer or invitation for acquisition or subscription of any shares of Mercator Medical S.A. There will be no public offer of the Company’s securities in the United States of America.
Neither the Prospectus nor the securities it covers have been registered, have been or will be the subject of registration, approval or notification in any country other than the Republic of Poland, in particular in connection with the provisions of Directive 2003/71/EC of the European Parliament and of the Council of 4 November 2003 on the prospectus to be published when securities are offered to the public or admitted to trading, or the U.S. Securities Act of 1933, as amended. The securities covered by this Prospectus may not be offered or sold outside the Republic of Poland (including in other countries of the European Union and the United States of America), unless such offer or sale could be legally made without the obligation to meet any additional legal requirements.
Any investor residing or established outside the Republic of Poland should familiarise themselves with the provisions of Polish law and the laws of other countries which may apply to it.